KRRO News and Press, Korro Bio Inc. From 11/13/25

2025-11-13 09:49:43 ET More on Korro Bio Seeking Alpha’s Quant Rating on Korro Bio Historical earnings data for Korro Bio Financial information for Korro Bio Read the full article on Seeking Alpha For further details see: Korro Bio stock fe...

CAMBRIDGE, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- CAMBRIDGE, Mass., November 12, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly p...

Ensysce Biosciences Inc. (ENSC) is expected to report $-0.85 for Q3 2025 IO Biotech Inc. (IOBT) is expected to report $-0.31 for Q3 2025 Lifeward Ltd. (LFWD) is expected to report $-0.14 for Q3 2025 Life360 Inc. (LIF) is expected to report $0.03 for Q3 2025 Pixelworks Inc. (PXLW) ...

CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and scientific conferences for the month of September: Citi's 2025 Biopharma Back to School Conference ...

2025-08-28 13:32:00 ET More on iShares Russell 2000 ETF: Housing: 5 More Signs Of A Rapidly Deteriorating Market Fed Narrows 11th Consecutive Quarterly Loss Due To Quantitative Tightening Losing Speed On The AI Superhighway Investors are getting ahead of them...

2025-08-12 12:22:37 ET More on Korro Bio Seeking Alpha’s Quant Rating on Korro Bio Historical earnings data for Korro Bio Financial information for Korro Bio Read the full article on Seeking Alpha For further details see: Korro Bio GAAP EPS...

Reeds Inc. (REED) is expected to report $-0.04 for Q2 2025 Jerash Holdings (US) Inc. (JRSH) is expected to report for Q1 2026 Churchill Capital Corp IX (CCIX) is expected to report for quarter end 2025-06-30 Verde Clean Fuels Inc. (VGAS) is expected to report for Q2 2025 Mobile In...

— Interim readout from Phase 1/2a REWRITE clinical trial of KRRO-110 on track for the second half of 2025 — Completed dosing of over 80% of planned REWRITE healthy volunteers across multiple single ascending dose (SAD) cohorts with no treatment emergent serious adverse...

Korro Bio Inc. (KRRO) is expected to report $-2.54 for Q2 2025

2025-08-11 18:45:12 ET Korro Bio, Inc. (KRRO) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 5.42%. The average open to low on the day of earnings was -6.07%. The average open to close ...